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PMS64 ANALYSIS OF HOSPITAL EVENTS MEANING IATROGENICITY, ANHEMIA
Vainchtock A 1 , Kosa M 2 , Diazaraque R 3 , Lamarsalle L 1 , Duru G 4 1 HEVA Health Evaluation, Lyon, France, 2 PFIZER FRANCE, Paris, France, 3 PFIZER, Walton Oaks, UK, 4 Université Caude Bernard, Lyon, France OBJECTIVES: Anaemia is prevalent among old individuals. Iron deficiency due to chronic gastrointestinal loss is a frequent cause. Non-steroidal anti-inflammatory drugs (NSAIDs) are a major cause of bleeding among osteoarthritis (OA) patients. Analysis of Hospital Events Meaning IAtrogenicity (ANHEMIA) study aims at assessing the demographic characteristics of anaemia in french OA patients and its impact on hospital length of stay (LOS). METHODS: Programme de Médicalisation des Systèmes d'Information (PMSI) database covers french hospital activity and is used by Health Authorities as resources use indicators for allocating and forecasting medical budget. Its Use to assess the epidemiological and economic burden of illness is recommended. Cross-linkage through the ICD-10 diagnosis codes allowed the identification of hospital stays with a main diagnosis of osteoarthritis (OA ) and Among these, 2 subpopulations according to the existence or absence of iron-deficiency anaemia (AN or AN-). ICD-10 diagnosis cancers were excluded. Four groups were established for analysis: OA AN-, OA AN in either private or public hospitals (PrH, PuH). RESULTS: All the groups analysis showed a higher percentage of women (p 0. Anaemia, is an important driver for extra-costs in hospitalized OA population. Since this population is likely to grow in the forthcoming years, every effort to reduce its incidence of anaemia should be considered. The two main procedures were posterior lumbar arthrodesis (procedure code LFDA004/0; n 68) and removal of herniated disc (procedure code LFFA002/0; n 111). For posterior lumbar arthrodesis surgery, the average LOS in Foch Hospital was 5.9 days compared to 8.9 days in the national data base (34% decrease). For herniated disc surgery, the average LOS in Foch hospital was 3.4 days compared to 5.3 days in the national data base (36% decrease). In 2007, Foch hospital avoided 215 days of hospitalization with the MAST, representing between a133,000 and a141,000 (a320-a340 per day). CONCLUSIONS: By lowering morbidity and reducing recovery time, MAST TM reduces costs of hospital stays. The reduction of hospital days may off-set any additional device costs. Further prospective research should be considered to validate our findings; however this is one of the first studies investigating systematically this subject. To estimate the influence of non-compliance on the risk of fractures in German osteoporosis patients treated with oral bisphosphonate (oBP) therapy. METHODS: IMS® Disease Analyzer database was used; includes 11 million patients from office-based physicians. Eligible osteoporosis patients (excluding malignant diseases, any anticancer or cytostatic hormone prescription, Paget's disease or AIDS) had data available 1-year before and after initiating oBP treatment (December 2004 -November 2007 . Compliance was measured as Medical Possession Ratio (MPR; prescribed to assumed number of therapy units). MPR 80% assumed compliance. MPR was calculated for patients on therapy up to 2 years. Fractures were identified by ICD-10 codes; only fractures 3 months after initiating oBP were included. The influence of compliance on time to fracture was determined by Kaplan-Meier and Cox regression analyses. The model was adjusted for gender, age, prevalence of fractures 1 year before index prescription, calcium/vitamin D co-prescription, continuation of the initial regimen after 6 months and after 1 year. RESULTS: A total of 4738 patients' data were analyzed: 1365 (28.8%) with previous fractures. The total number of patients receiving oBP treatment was 177 (3.7%) daily, 4367 (92.2%) weekly and 194 (4.1%) monthly. After 2 years, 14.5% (daily), 12.2% (weekly), and 9.7% (monthly) of patients experienced a fracture. The time to fracture was significantly longer for compliant versus non-compliant patients (log rank test; p 0.013). Compliance was associated with a 26% (95% CI 10-39%) decrease in the fracture rate versus non-compliance. Higher age ( 60 years) (44% increase; 95%CI 3-100%) and previous fractures (29% increase; 95%CI 5-57%) were associated with a significantly higher risk of fractures. CONCLUSIONS: Patients receiving oBP therapy who are compliant have a decreased risk of fractures versus non-compliant patients. Older patients and those with fracture history are particularly at risk of fracture. These findings highlight the need to improve compliance to reduce the risk of osteoporosisassociated fractures. To examine the effect of medication choice between duloxetine and pregabalin on medication compliance outcomes as well as direct health care costs among patients with fibromyalgia. METHODS: A retrospective cohort study design was used with a large US national commercial health care claims database over [2005] [2006] [2007] . Fibromyalgia patients aged 18-64 who initiated (no pill coverage in the previous 90 days) duloxetine or pregabalin in 2006 were selected, with the first initiation date as the index date. All patients included had continuous enrollment in the 12
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